Nektar Therapeutics
HealthcareNASDAQ:NKTR · NASDAQ Global Select
Market Cap $1.16B Beta 1.15 P/E (TTM) -9.3
$59.38 +0.29%
+$0.17 today
52W Low $7.99High $109.00
Vol 0.53M · Avg 1.02M
EPS (TTM)-$6.39
Biotechnology
Financial Health
Check the balance sheet before trusting the story
Use cash, debt, liquidity, and leverage metrics to understand whether the company has enough financial strength to support its plans through weaker periods.
Cash & Equivalents
—
Long-Term Investments
—
Total Debt
—
Debt/Equity
—
Debt/Assets
—
Cash Ratio
—
Quick Ratio
—
Current Ratio
—
Competitor Health
Peer financial health comparison
No competitor data available.
Is NKTR's balance sheet healthy?
Nektar Therapeutics (NKTR) has a current ratio of 10.21, a quick read on short-term liquidity.
How leveraged is NKTR?
Debt to equity is 0.25, which helps judge how much financing risk sits on the balance sheet.
Explore More
Continue the stock analysis
Jump to another research area for this company.
OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.FilingsOpen recent filings alongside price history for deeper research.